ABMT may contribute to an improved clinical outcome. Further, patients receiving a PSCT may be more A majority of patients with intermediate or high-grade responsive to adjuvant immunotherapy following transnon-Hodgkin's lymphoma (NHL) who are treated with plantation. high-dose chemotherapy (HDT) and hematopoietic stem Keywords: PSCT; BMT; immunity; T cell; NHL; NK cell transplantation subsequently relapse. Until recently, cell F transplantation was associated with high morbidity and mortality and the focus was on improving the safety of this procedure. However, the use of growth factors and other supportive measures has successfully reduced High-dose chemotherapy (HDT) supported by hematopotreatment mortality to less than 5%. Therefore, new ietic stem cell transplantation and growth factor adminisstrategies need to be developed to eliminate the growth tration is increasingly used for patients with cancer. 1-3 Leuof any occult tumor cells reinfused with the stem cell kocyte and platelet recovery is more rapid following products and the tumor cells remaining in the patient.
PSCT and ABMT in humans. [15] [16] [17] [18] Overall, there appears to more rapid increase in the frequency of T be wide phenotypic variability of cells in the suppressor/effector (CD8 + ) cells, B (CD19
+ ) cells, CD34
+ apheresis/transplant products themselves. 14 A significant cells, polymorphonuclear leukocytes (PMN) and memincrease in the frequency of CD8 + cells in the peripheral ory T lymphocytes (CD45RO + ). The CD4:CD8 and blood (PB) following both forms of transplantation and an CD45RA:CD45RO ratios were consistently higher in inversion in the CD4:CD8 cell ratio has been observed as the PSCT group as compared to ABMT suggesting an
well. An impairment in T cell function following both improved ratio of T helper to T effector/suppressor cells forms of transplantation was also observed. In the present and naive T cells. The differences in cellular phenotype paper we report a more rapid phenotypic and functional translated into improved T cell function (PHA reconstitution of immune cells in the PB following PSCT mitogenesis) and T cell help (pokeweed mitogenesis).
as compared to ABMT. This has clinical significance as the In addition, there was an accelerated reconstitution more rapid immune reconstitution may contribute to the of NK cell activity following PSCT as compared to apparent therapeutic advantage with PSCT when compared ABMT. The more rapid reconstitution of NK and T to ABMT. HDT and PSCT and centrifuged for 20 min at 1400 r.p.m. After centrifugation the aqueous layer was removed and the mononuclear (n = 56) or ABMT (n = 60) at the University of Nebraska Medical Center (UNMC) were entered into these studies.
Materials and methods

Cell isolation
cell layer transferred to another tube. The cells were then washed twice in HBSS and adjusted to 4 × 10 6 /ml in RPMIWritten informed consent for PB collection and autologous transplantation was obtained from each patient. Patient 1640 (Gibco BRL) containing 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA), 10 mm HEPES characteristics are shown in Table 1 . Peripheral blood progenitor cells were mobilized with granulocyte-monocyte (Research Organics, Cleveland, OH, USA), 40 mg/ml Gentamycin (Gibco BRL) and 0.3 mg/ml l-glutamine (Gibco colony-stimulating factor (GM-CSF) by intravenous administration of 250 g/m 2 and a target dose of 6. After incubation and washing, streptavadin APC was added as the third fluorochrome. The detailed phenotypic analysis у500/mm 3 on 2 consecutive days. Patients received either BEAC as their therapy or BECH which was given to 47 of the antigens of interest, their color combination and the cell populations that they detect are shown in Table 2 . This patients who participated in a phase I/II trial for the treatment of high risk disease and who were refractory to pri- Table also contains the cocktail groupings for the isotype controls. The clone, source and isotype of the labeled antimary therapy or had a therapy resistant relapse. 19 Patients received a PSCT if they had BM involvement or a history bodies are shown in Table 3 . All three-color data was acquired on a Becton Dickinson of BM involvement, otherwise they received a BMT. During the latter period of patient accrual, beginning in (San Jose, CA, USA) Facstar Plus flow cytometry using a 40 mW argon laser tuned to 488 nm and a 100 mW krypton December 1993, patients who were otherwise candidates for BMT were randomized to BMT vs PSCT as part of a laser tuned to 647 nm for excitation. Detailed three-color data analysis was performed using the Paint-A-Gate Plus phase III trial. PB samples were obtained prior to mobilization and apheresis or BM harvest and on or about 15, 30, and Lysis II software from Becton Dickinson. Three-color 75 and 100 days after transplantation for immunologic evaluation. These blood samples were obtained using proto- made in 96-well flat bottom plates. The responder cells were then added (50 l) together with PHA (50 l) to achieve 0.5 g/ml. Cells were then cultured at 37°C and 5% CO 2 for 4 days in RPMI 1640 medium containing 10% flow cytometry analysis was undertaken to limit the number FBS. The mitogenic response by the responder population of cells required for analysis and to facilitate the identifiwas assayed by pulsing with one Ci/well of 3 H-thymidine cation of phenotypic subpopulations expressing activationover the final 18 h of culture. Cells were harvested with maturational markers. The absolute number of a specific a 96-well harvester onto fiberglass filters and radioactivity cellular phenotype was determined by multiplying the counted in a Packard Multi-well Beta Counter. cellularity determined on a Serono 9000 Blood Analyzer (Serono Baker Diagnostics, Allentown, PA, USA) by the Statistics phenotypic frequency.
SPSS for Windows was used for the independent samples t test for equality of means (unequal). Levene's test for
Mitogen response
homogeneity of variances was also undertaken and if sigMononuclear cells were cultured in the presence of phynificant (ie the data set did not follow a normal distribution) tohemagglutinin (PHA) or pokeweed mitogen (PWM) at a the non-parametric Mann-Whitney U test was used. concentration of 1 × 10 5 cells/well in 96-well flat bottom Minimal loss to follow-up occurred in these studies. On microtiter plates (Falcon, Becton Dickinson Labware, Linday 100, three ABMT and five PSCT were not examined coln Park, NJ, USA). Cells were cultured for 54 h in either and on day 365, five ABMT and eight PSCT were lost. the presence or absence of 5 g/ml, 2.5 g/ml, 0.5 g/ml Therefore, all of the patients were studied at each time point PHA or PWM (Difco, Detroit, MI, USA) at a 1:400, 1:800 and in all the assays except as noted above. or 1:1600 dilution (5 g/ml, 2.5 g/ml and 1.25 g/ml, respectively). For the final 18 h of culture 1 Ci 3 H-thymidine (Amersham Life Sciences, Arlington Heights, IL, Results USA) was added (total 96 h). The cells were then harvested onto fiberglass filters using a 96-well harvester (Packard Stem cell, monocyte and polymorphonuclear neutrophil Instruments, Downers Grove, IL, USA). The filters were (PMN) reconstitution allowed to air dry, scintillation cocktail added, and the samples counted in a Packard Multi-well Beta Counter.
The frequency of PMNs normalized to pretherapy levels by day 30 post-ABMT and day 75 following PSCT ( Figure 1 ). Specific incorporation of 3 H-thymidine was compared to control cells (no mitogen stimulus).
The monocytes and PMNs are identified by flow cytometric + cells used a total cell gate. The gates used for monocytes and PMN are shown in Figure 2 . The absolute number of cells ± standard error of the mean/cc 3 was calculated by multiplying the cellularity times the frequency. * = P р 0.05.
analysis following gating based on side scatter and CD14 the mean is shown for all data. The increase in PMN frequency following ABMT as compared to PSCT was sigstaining ( Figure 2 ). As anti-CD14 binds predominantly to monocytes and granulocytes, but does not bind to lymphonificant (P р 0.001) on day 30 following transplantation. In addition, the absolute number of PMNs was largely recocytes, this approach is very accurate. The standard error of The T cell receptor is comprised of multiple proteins and patients as compared to PSCT patients (P р 0.001). In this can be subdivided into cells expressing the alpha-beta (␣/␤) cohort of patients there was a significant increase in the heterodimer which is the predominant phenotype and the frequency (P = 0.006) and absolute number of monocytes gamma-delta (␥/␦) heterodimer. In these patients, the fre-(P = 0.0381) prior to chemotherapy in the ABMT as comquency and absolute number of TCR-␣/␤ + cells was similar pared to the PSCT patients. In contrast and perhaps due to following ABMT and PSCT ( Figure 5 ). In contrast, the the numbers of monocytes infused in the PSC product, 14, 21 TCR-␥/␦ + cells were significantly increased 15 and 30 days there was a significant increase in the frequency of CD14 + following HDT in PSCT patients compared to ABMT monocytes on day 15 and 30 following HDT and PSCT patients. This increase was observed in the frequency (P = 0.016 and 0.05, respectively) as compared to ABMT.
(P = 0.006 and 0.024, respectively) and absolute number However, no significant difference in the absolute number of TCR-␥/␦ + cells (P = 0.001 and 0.029, respectively). The of CD14
+ monocytes was observed between the ABMT and increase in TCR-␥/␦ + cells in the PSCT patients normalized PSCT patients following transplant. Studies on the freby day 75 when they returned to pretransplant levels. quency and absolute number of CD34 + stem cells in the Cells expressing the CD45RA isotype have a naive PB revealed a trend for an increase in the frequency of phenotype while T cells expressing CD45RO are con-CD34 + cells following ABMT as compared to PSCT which sidered mature memory T cells. Following PSCT there was was significant on day 30 (P = 0.045) but not significant at a significantly greater frequency of CD45RA + cells on day other times. Furthermore, no difference in the absolute 15 and 30 (P р 0.001 and P = 0.004, respectively) as comnumber of CD34
+ cells was found either before or followpared to the ABMT patients as well as a greater absolute ing transplantation. The frequency of CD34
+ cells in the number of these cells on day 15 (P = 0.017). In contrast to PB was variable due in part to a low frequency which was the increase in CD45RA + cell frequency and absolute nummost notable on day 15 following transplantation.
ber, the frequency (day 30) and absolute numbers (day 15) of CD45RO + cells were significantly (P = 0.028 and 0.007, respectively) greater following ABMT as compared to PSCT. The disassociation in the CD45RA
+ vs CD45RO (Figure 3 ). This suggested that 15 days rapidly following PSCT. In addition, the studies on the after transplant CD3
+ cells had returned to their pretrans-CD4:CD8 ratio suggested a more rapid immune reconstiplant values. In contrast, the frequency of CD4 + cells was tution following PSCT as compared to ABMT with a presignificantly higher 15 days following PSCT as compared dominance of helper as compared to suppressor/effector to ABMT (P = 0.003) but thereafter were statistically simicells. lar. In agreement with the increase in the frequency of CD4 + cells on day 15 following PSCT there was a decrease NK cell, IL-2 receptor and CD4 − CD8 − ␣/␤ + phenotype (P = 0.001) in the frequency of CD8
+ cells compared to the reconstitution ABMT patients at this timepoint. Further, the CD4:CD8 cell ratio (Figure 4 ) was consistently increased on days 15, CD56 expression, a phenotypic measure of NK cells was 30 and 75 but not day 100 following HDT in the patients significantly increased ( Figure 6 ) 15 and 30 days following receiving PSCT as compared to an ABMT (P = 0.047, PSCT as compared to ABMT (P р 0.001 and P = 0.002, 0.049, and 0.01, respectively). There was a trend for an respectively). However, no significant change was noted in increase in the frequency of CD19 + B cells following the absolute number of CD56 + cells. The frequency of NK ABMT which achieved significance on day 30 (P = 0.002) cells, rigorously defined as CD3 − CD8 + CD56 + cells, was following HDT. In addition to this increase in the frequency also increased on day 15 following PSCT as compared to of CD19 + cells, there was a significant increase in their ABMT (P = 0.001). There was also a significant increase absolute number (P р 0.001) on day 30. A significant in the absolute number of the CD3
+ cells on increase in other B cell markers was also observed on day day 15 following PSCT as compared to ABMT. The fre-30 including an increase in the absolute numbers of CD10 + quency of CD56 + cells on day 15 following PSCT was sig-(P = 0.037), CD23 + (P = 0.012) and IgM + (P = 0.05) cells nificantly greater than that observed in normal PB (results following ABMT as compared to PSCT (results not not shown (P = 0.02)) or pretransplant (P = 0.041), suggestshown). It should be noted, that in contrast to the granuloing that an overcompensation following transplantation cyte series where the absolute number of cells is critical, may have occurred as a defense mechanism. On days 15 immune function is dependent on the cellular freand 30 post-HDT, the frequency of CD25 + cells (IL-2␣ quency. 23, 24 Therefore, the CD4:CD8 ratio and frequency of receptor) was increased following PSCT as compared to a lymphoid subset is a more accurate reflection of immune ABMT (P р 0.001 and 0.001, respectively). Similarly, the absolute number of these cells was increased on days 15 response potential than the absolute cell number. Cellular function cells, 25 was significantly higher on days 15 and 30 following PSCT (P р 0.001 and P р 0.001, respectively) as com-NK cell activity ( Figure 7 ) was increased following PSCT as compared to ABMT in the PB of transplant patients on pared to the levels in the PB following ABMT. Similarly, PSCT may be reflected in the increased T cell function and CD4:CD8 ratio as pokeweed mitogenic response is reliant pared to that observed in the PB of normal individuals (results not shown) and pretransplant levels (P = 0.017 and on T helper cell activity. P = 0.034, respectively). No significant difference was observed in the NS cell activity in the PB of PSCT and ABMT patients at any time following transplantation Discussion although 15 days following either form of transplantation significantly higher levels were observed compared to norThis study compared immune cell phenotypic and functional recovery during the first 100 days following PSCT mal donors (results not shown). The similar level of NS activity (Figure 7 ) differed from the phenotypic results and ABMT in 114 patints. Whether ABMT or PSCT results in a more rapid immunological recovery [15] [16] [17] [18] has been conwhere on days 15 and 30 the frequency and absolute number of CD4
The majority of studies have involved comparisons of immune reconstitution following ABMT or PSCT and ␥/␦ + cells were increased following PSCT as compared to ABMT (Figure 6 ). Note, although there were no signifias compared to steady state PB in normal donors or to pretransplantation levels. Abnormal immune phenotype and cant differences in the NS activity between the ABMT and PSCT PB samples, the suppressor cell activity was signififunction following allogeneic or autologous BMT as well as PSCT have previously defined an imbalance in the cantly increased compared to that observed in the PB of normal donors (10 ± 3.9% suppression).
CD4:CD8 cell ratio, diminished T cell proliferative responses, and/or a depressed IL-2 production or a failure The PHA mitogen response returned to pretransplant levels in the PB of PSCT patients more rapidly than it did in to respond to endogenous IL-2. In addition, abnormal B cell function as measured by phenotype, immunoglobulin the ABMT transplant patients. In addition, the PHA response on days 30, 75 and 100 was significantly greater production and proliferation in response to PWM 17 has been reported as well. Abnormal cytokine production following PSCT as compared to ABMT (P р 0.001, 0.001 and P = 0.028, respectively). The PHA response even preand/or levels of soluble cytokine and T cell receptor levels in the serum have also been reported. 18 It should be noted transplant in the PSCT patients was significantly lower than that found in normal individuals (P = 0.0017) and never that one of the major differences between PSCT and ABMT, other than the product, is the administration returned to levels seen in normal donors (186 791 ± 17 131 c.p.m.) folowing PSCT. Note, the CD3 + cell freof mobilizing GM-CSF which may have some immunemodifying effects. quency at all of these timepoints was identical between the ABMT and PSCT patients although the CD4:CD8 ratio as Specific immune reconstitution after BMT has been extensively studied since the 1970s with the demonstration shown in Figure 4 differed on days 15, 30 and 75 and was below normal values (1.46 ± 0.037) at all times post-transof long-standing cellular and humoral immunodeficiency post-transplant. 6, 16, 17, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] Monocyte and NK cell counts and plantation. Thus, it appears that the frequency and absolute numbers of the CD3 + T cells normalized following ABMT function recover rapidly, usually within 1 month post-transplantation. 32, [41] [42] [43] [44] [45] [46] [47] [48] The recovery of absolute T cell counts although they were not functional as measured by PHA mitogenesis. Further, the PWM response was greater folalso occurs fairly rapidly, generally within 6 months posttransplantation; although, markedly decreased CD4:CD8 lowing PSCT as compared to ABMT on days 30 and 75 Figure 2 ) was used and the frequency reported was corrected for total cells. The absolute number of cells ± standard error of the mean/cc 3 was calculated by multiplying the cellularity times the frequency. * = P р 0.05.
cell ratios occur for a longer time period post-transfollowed by CD8 + cells, B cells, and then later by CD4 + cells. 14, [16] [17] [18] 33 There was also a suggestion that ␥/␦ cells plant. 16, 26, 29, 30, 32, 46, [48] [49] [50] [51] [52] [53] [54] B cell numbers generally recover earlier than T cell levels, 16, 32 although their functional were transiently increased shortly following transplantation and that there were abnormalities in the CD45RA and reconstitution, perhaps due to low helper T cell activity, or an oligoclonal expansion 18, 38, 39 is slower than the recovery CD45RO cell frequencies. 14, 55 The data from the present study demonstrates that there is a rapid recovery of lymphoin the frequency or absolute number of B cells. Overall, following both ABMT and PSCT there has been a trend cytes in addition to the reconstitution of neutrophils after PSCT and ABMT; although, there is a trend for a more for monocytes and NK cells to recover most rapidly to be rapid reconstitution of neutrophils following ABMT as PSCT and ABMT, but to a significantly greater extent following ABMT. compared to PSCT. Furthermore, cells with the CD4 + cell phenotype reconstitute more rapidly following PSCT while This study observed a significantly faster immunological reconstitution following PSCT as compared with ABMT in there was a trend for an accelerated reconstitution of CD8 + cells following ABMT as compared to PSCT. Overall, there NHL patients transplanted during the same period. Following PSCT and ABMT there was also a chronic depression was a clear tendency for the CD4:CD8 cell ratio to be significantly lower following ABMT as compared to PSCT.
in B and T cell function. 6, [14] [15] [16] [17] 26, 37, [55] [56] [57] [58] [59] In this study, high levels of suppressor cell activity were observed following Regardless, the absolute number of T cells was rapidly reconstituted although their functionality was not. Indeed both ABMT and PSCT returning to pretransplant levels by day 100. Thus, suppressor cell activity may provide, at least and perhaps secondary to a lower level of T cell help, B cell responsiveness to PWM remains suppressed following in part, the origin of the decreased T cell functions. Four 1 suppressor:responder cell ratio using the cells described in Figure 1 as the suppressors and normal donor lymphocytes as responders. The pokeweed mitogenesis was with a 1:1600 dilution of Difco PWM and the data otherwise was described for PHA. * = P р 0.05.
other studies have directly compared immunologic reconstiplantation, there was a significant increase in CD20 + cells tution following ABMT and PSCT. Henon et al 15 in a study following ABMT as compared to PSCT. They concluded of 20 ABMT and 20 PSCT patients, compared ABMT that immune recovery occurs more rapidly after PSCT as patients with acute lymphoblastic leukemia and PSCT compared to alloBMT but that there were minimal differpatients with acute myelogenous leukemia (AML). They ences between ABMT and PSCT. In contrast, Guillaume reported, but did not show data, that T cell subsets had an et al 18 compared IL-2 mRNA levels in PB cells from a increased CD8 frequency within the first 3 months postlimited number of PSCT and ABMT patients at disparate transplantation in both ABMT and PSCT patients. A time points and observed similar levels of production. decrease in CD4
+ cells was also suggested leading to a Kiesel et al 17 also evaluated B cell function after PSCT decrease in the CD4:CD8 ratio with a median ratio of and ABMT and found no difference in B cell function 0.3 ± 0.2. Further, they suggested that the CD4:CD8 ratio between ABMT and PSCT patient groups; however, they did not return to normal within 120-180 days post-transdid report that compared to normal subjects, the majority plantation and did not vary between the two groups. They of these autografted patients had a suppressed B cell also suggest that the kinetics of B cell reconstitution did function. not differ in the first 9 months post-transplantation with the This study represents a comparison of PSCT (cytokine number of CD19 + and/or CD20 + B cells normalized by 1 mobilized) and ABMT in a similar patient population. month post-transplantation and increased to supernormal Given the number of patients studied with a single tumor levels by day 120-180.
type, the changes observed are likely to be reflective of In a second study, Roberts et al 16 examined the immune immune recovery following both forms of transplantation phenotype of the cells in the PB of patients receiving (at least within NHL patients). Further, the more rapid ABMT and PSCT. In their study, the reconstitution of 49 immunologic reconstitution including significantly patients receiving PSCT, including 30 AML patients in improved CD4:CD8 cell ratio, NK cell number and funcearly first remission, was compared to seven patients who tion, PWM and PHA mitogenic response, and CD45RA received ABMT which included four NHL and one Hodgresponse following PSCT as opposed to ABMT have kin's disease patient. The statistical comparison of PSCT potential clinical applicability by a facilitation of adjuvant to ABMT revealed no significant difference in total lymtherapeutic manipulation. phocytes, CD3 + , CD8
+ , CD4 + , or CD25 + cells at any time following transplantation. However, at 6 months post-trans-atopoietic and immune recovery after autologous bone marrow
